Medication underdosing and underprescribing: Issues that may contribute to polypharmacy, poor outcomes

Formulary

Volumn 48, Issue 6, 2013, Pages 194-196

  Halczli, Alyssa ^a   Woolley, Adam B ^a,b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG UNDERDOSE; DRUG USE; HEALTH CARE COST; HUMAN; MEDICAL EDUCATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; POLYPHARMACY; PRESCRIPTION; REVIEW;

EID: 84885106684     PISSN: 1082801X     EISSN: 19381166     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, Roberts M. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy. 2006;26:1578-1586.
2. Agency for Healthcare Research and Quality. U.S. Department of Health & Human Services. National statistics on all hospital stays. Outcomes for all discharges. 2010. Available at http:// hcupnet.ahrq.gov/HCUPnet.jsp. Accessed November 11, 2012.
3. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy. 1996;16:701-707.
4. Cherubini A, Corsonello A, Lattanzio F. Underprescription of benefcial medicines in older people: causes, consequences, and prevention. Drugs Aging. 2012;29:463-475.
5. Rambhade S, Chakarborty A, Shrivastava A, Patil UK, Rambhade A. A survey on polypharmacy and use of inappropriate medications. Toxicol Int. 2012;19:68-73.
6. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of highrisk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy. 2005;25:1636-1645.
7. Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother. 2010;8:63-72.
8. Kojima G, Bell C, Tamura B, et al. Reducing cost by reducing polypharmacy: the polypharmacy outcomes project. JAMDA. 2012;13:818. e11-818. e15.
9. Kuijpers MAJ, van Marum RJ, Egberts ACG, Jansen PAF, and the OLDY (OLd people Drugs & dYsregulations) study group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2007;65:130-133.
10. van den Heuvel PML, Los M, van Marum RJ, Jansen PAF. Polypharmacy and underprescribing in older adults: rational underprescribing by general practitioners [letter]. J Am Geriatr Soc. 2011;59:1750-1752.
11. Hawkins-Simons D. Heart failure programs take aim at readmits. Pharmacy Practice News. January 2013. Available at http://www.pharmacypracticenews. com.
12. Barry PJ, Gallagher P, Ryan C, O'Mahony D. START (screening tool to alert doctors to the right treatment)-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing. 2007;36:632-638.
13. Rodgers JE, Stough WG. Underutilization of evidence-based therapies in heart failure: the pharmacist's role. Pharmacotherapy. 2007; 27:18S-28S.
14. Paquin AM, Archambault E, Harrington MB, et al. The PILL service: enhancing medication safety after hospital discharge. Available at http://www.ashpfoundation.org/2012Exc ellenceAwardeeAbstract. Accessed April 3, 2013.
15. Detail document. STARTing and STOPPing medications in the elderly. Pharmacist's Letter/ Prescriber's Letter. September 2011.
16. ICD-10 spotlight: know the codes (drug underdosing). Partners in health update. Available at http://www.amerihealth.com/pdfs/providers/ claims_and_billing/icd_10/icd_10_spotlight_ ah.pdf. Accessed April 19, 2013.